Technological bells and whistles are nice, innovative processes crafted at the granular level are terrific, but none of it matters much if you don’t have the right people in place, experts gathered for the 4th Annual ACRP Executive Summit in Seattle affirmed April 30. To succeed, “you need great relationships all down the line,” said […]
“We have a big challenge when we talk about oversight of research…[and] we need to recognize that investigators are human” and may regrettably behave in ways leading to noncompliance or research misconduct, says Ernest D. Prentice, PhD, associate vice chair for academic affairs with the University of Nebraska Medical Center. Presenting a session on “Breaches […]
An exciting regulatory willingness to consider new ways of clinical trial oversight is the single biggest factor driving innovations in the industry. That’s the assessment of Terri Hinkley, Workforce Innovation Officer for the Association of Clinical Research Professionals (ACRP). “We’re a risk-averse industry,” she told attendees kicking off day two of ACRP’s 2017 Meeting & […]
The future of revolutions in communication between study sites and sponsors is being crafted even now through the Shared Investigator Platform initiative described by project members yesterday in a session at the ACRP 2017 Meeting & Expo in Seattle. As described by Summer Iverson, associate director of global clinical trial execution for Pfizer, and Kelly […]
Data managers play a critical, and perhaps under recognized, role in fully realizing the potential of risk-based monitoring (RBM), Jan Peterson, senior regulatory affairs manager and project director at Emmes Corporation, told attendees of the Association of Clinical Research Professionals (ACRP) 2017 Meeting & Expo in Seattle April 29. RBM remains a murky concept in […]
